Drugs / Sentra PM
last change Dec 2008 re-read 2 minutes ago

Sentra PM

Developed for
sleep disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01468038 Comparator Apr → Oct 2008 sleep disorder Targeted Medical Pharma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sentra PM ClinicalTrials.gov intervention name — accepted as the source's own label NCT01468038
Route Oral “twenty-six subjects will be randomized to a two week ingestion of Sentra PM at bedtime” NCT01468038